Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients

Benzer Materyaller

• Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
  Yazar:: Press, Richard D., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
  Yazar:: Sherbenou, Daniel W., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
  Yazar:: Elias, Marjanu Hikmah, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Novel mutations in the RING-finger domain of BRCA1 gene in clinically diagnosed breast cancer patients
  Yazar:: Kumar, Pasupuleti Santhosh, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib
  Yazar:: Benjamin, Esther Sathya Bama, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)